Elisabeth Rosenthal Triumphant music plays as cancer patients go camping, do some gardening, and watch fireworks in ads for Opdivo+Yervoy, a combination of immunotherapies to treat […] ...

Novartis' Pluvicto is expected to dominate the market for radioligand therapies for prostate cancer, with ...

Dr Sarah Fitzgibbon, who was diagnosed with bowel cancer 10 years ago, feels lucky that for six years after being ...

During a Case-Based Roundtable® event, Virginia F. Borges, MD, MMSc, discussed treatment selection for a patient with ER+, ...